Position in AMGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,123,285
-$25,772 QoQ
Shares Held
8,625
-3.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.03%
of 13F equity value
Holder Rank
#1,053
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Front Row Advisors LLC holds $11,088,191 across 9 Drug Manufacturers - General names. AMGN ranks #2 (28.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
24,207 | $6,091,449 | |
| 2 | AMGN |
Amgen Inc
This page
|
8,625 | $3,123,285 | |
| 3 | JNJ |
Johnson & Johnson
|
4,871 | $1,237,087 | |
| 4 | LLY |
ELI LILLY & Co
|
287 | $344,236 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,497 | $189,130 | |
| 6 | PFE |
Pfizer Inc
|
2,210 | $53,216 | |
| 7 | MRK |
Merck & Co., Inc.
|
297 | $38,164 | |
| 8 | GSK |
GSK plc
|
221 | $11,584 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,123,285 | 8,625 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,149,057 | 8,950 | Shares | Sole | 2026-05-19 | |
| 2025-12-31 | $2,911,422 | 8,895 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,543,750 | 9,014 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $2,518,194 | 9,019 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $2,810,181 | 9,020 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,415,350 | 9,267 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $3,009,763 | 9,341 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,933,593 | 9,389 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $2,670,333 | 9,392 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,683,482 | 9,317 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $2,537,631 | 9,442 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $2,132,058 | 9,603 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $2,320,074 | 9,597 | Shares | Sole | 2023-05-23 | |
| 2022-12-31 | $2,589,630 | 9,860 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $2,255,127 | 10,005 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $2,429,350 | 9,985 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,418,925 | 10,003 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $2,139,014 | 9,508 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $2,003,800 | 9,423 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $2,315,137 | 9,498 | Shares | Sole | 2021-08-23 | |
| 2021-03-31 | $2,345,531 | 9,427 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $2,130,668 | 9,267 | Shares | Sole | 2021-02-25 | |
| 2020-09-30 | $2,389,612 | 9,402 | Shares | Sole | 2020-11-30 | |
| 2020-06-30 | $2,250,340 | 9,541 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $1,953,709 | 9,637 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||